Verheugen statement gives away Euro Commission thinking on tissue products
This article was originally published in Clinica
Executive Summary
The European Commission is in the process of completing its legislation on "innovative pharmaceuticals" with the "long-awaited regulation on advanced therapies and tissue-engineered products".